Obs & Gyne Conference
29 - 30 January 2024 | Dubai World Trade Centre
Elevate your understanding of women's health at the 16th Obstetrics & Gynecology Conference, happening from January 29th to 30th, 2024. This highly anticipated two-day event serves as a dynamic gateway to cutting-edge insights across diverse subjects.
14.5 CME points
Theme: From evidence to practice: Transforming obstetrics and gynecology care through clinical case integration
Elevate your understanding of women's health at the 16th Obstetrics & Gynecology Conference, happening from January 29th to 30th, 2024. This highly anticipated two-day event serves as a dynamic gateway to cutting-edge insights across diverse subjects.
Engage in interactive discussions on HPV vaccines, their role in preventing STDs and gynecological cancers, and explore the ethical dimensions involved. Immerse yourself in evidence-based approaches to Hormone Replacement Therapy and delve into adolescent gynecological issues, recurring pregnancy loss, and innovative treatments. Participate in compelling debates, including niche repair post-caesarean scar pregnancies and the risks and rewards of VBAC, with ample opportunities for audience involvement.
Explore the synergy between heart disease and obstetrics, along with indications for cervical cerclage. Embrace the world of breastfeeding, contraception practices, and health in women across age groups, while actively contributing to the dialogue.
Join us in this transformative event, where interactive sessions foster connections, empower learning, and collectively shape the future of Obstetrics and Gynecology.
What's new?
• Importance of HPV vaccinations
• Focus on clinical practice-based topics
• Case study presentations
CME provided by:
Benefits of attending:
• Review the intricacies of HPV dynamics by focusing on effective HPV vaccination programs and their pivotal role in cancer prevention.
• Examine the benefits and risks of modern Hormone Replacement Therapy (HRT).
• Diagnose complex pathologies by navigating the challenges of complex ovarian pathology and Recurrent Pregnancy Loss (RPL)
• Evaluate contraceptive choices and enhance compliance strategies across reproductive ages.
Key topics
• The importance of an effective HPV vaccination programme for gynaecological cancer prevention in the MENA region
• Investigation and management of congenital uterine abnormalities
• Plenary session: Evidence based investigations and management for recurrent pregnancy loss: What does the literature say and how do we put it into practice?
Who will be attending?
• Gynaecologists
• Obstetricians
• Obs-Gyn Specialists/Consultants
• Women's Health Physicians
• Midwives
• Nurses
• Family Physicians
• Women's Health Physicians
Scientific committee
Activity Director:
Dr Tristi Muir, MD, Chair, Women's Health Institute, Cleveland Clinic, Ohio, USA
Conference Co-Chairs:
Dr Jeremy Hawe, Consultant Gynaecologist & Chief of Gynaecology, Corniche Hospital, Abu Dhabi, UAE
Dr. Sarah Francis, Consultant Obstetrician and Gynaecologist, American Hospital, Dubai, UAE
Exclusive healthcare leadership partner
